Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY - Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $22.76 and last traded at $22.99, with a volume of 213654 shares trading hands. The stock had previously closed at $23.78.
Daiichi Sankyo Price Performance
The company has a debt-to-equity ratio of 0.06, a current ratio of 2.77 and a quick ratio of 2.11. The stock has a 50 day moving average price of $26.60 and a two-hundred day moving average price of $31.59. The firm has a market capitalization of $43.22 billion and a price-to-earnings ratio of 26.34.
Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.22 earnings per share for the quarter. Daiichi Sankyo had a return on equity of 14.53% and a net margin of 13.62%. As a group, analysts expect that Daiichi Sankyo Company, Limited will post 0.73 EPS for the current year.
Daiichi Sankyo Company Profile
(
Get Free Report)
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Featured Stories
Before you consider Daiichi Sankyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.
While Daiichi Sankyo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
